Atlas Trials

A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer

Clinical trial NCT04186156 · WITHDRAWN

Trial details

NCT number
NCT04186156
Sponsor
Karus Therapeutics Limited
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Tract Cancer
Start date
2020-03-05
Primary completion
2023-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.